Current role
Terence Rooney, M.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Terence Rooney, M.D.
Kymera Therapeutics, Inc. reported in an 8-K filed July 27, 2026 that Terence Rooney, M.D. was appointed Chief Medical Officer, effective July 27, 2026.
“Effective July 27, 2026, Terence Rooney, M.D., will succeed Dr. Gollob as CMO of the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Kymera Therapeutics, Inc. (KYMR)
SEC 8-K
Current2026-07-27–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Kymera Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Bruce Jacobs CFO
- Jeremy Chadwick COO
- Jeremy Chadwick, Ph.D. COO
- Brian R. Adams General Counsel
- Brian R. Adams, J.D. General Counsel
- Bruce Booth Board Member
- Elena Ridloff Board Member
- Felix J. Baker, Ph.D. Board Member
- Gorjan Hrustanovic, Ph.D. Board Member
- John Maraganore Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.